N-PORT filing recap · March 2024

What did Ariel Appreciation Fund buy in March 2024?

Reported stock-position changes between this filing and the previous one. These are Ariel Appreciation Fund's own holdings, not the firm's.

Stock value

$1.06B

Positions

Estimated turnover

17.5%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

LAZLazard, Inc.$26.67Mreported value+637.1K shares BIOBio-Rad Laboratories, Inc.$11.82Mreported value+34.2K shares

Increased positions

MATMattel Inc /de/$39.61Mreported value+199.0K shares+11.1%GNRCGenerac Holdings Inc.$31.20Mreported value+10.4K shares+4.4%CLBCore Laboratories Inc.$27.92Mreported value+331.1K shares+25.4%NOVNov Inc.$24.23Mreported value+325.9K shares

Reduced positions

NTRSNorthern Trust Corp$45.15Mreported value-21.8K shares-4.1%GSThe Goldman Sachs Group, Inc.$42.11Mreported value-8.5K shares-7.8%CRLCharles River Laboratories International, Inc.$39.10Mreported value-8.8K shares-5.7%SCHWSchwab Charles Corp$34.00Mreported value-95.0K shares

Exited positions

LAZLazard, Inc.$24.79Mprior reported value-712.5K shares-100.0%SNASnap-On Inc$7.89Mprior reported value-27.3K shares-100.0%